← back to search

Petra Ross‐Macdonald

Bristol-Myers Squibb (United States) · GB
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Fungal and yeast genetics research, and Protein Degradation and Inhibitors.
h-index
33
citations
16,133
works
111
NIH funding
—
primary concept
Biology
email
✉ Find email ↗

Recent publications

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
Nature Communications 2021cited by 163position: middledoi
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
Nature Medicine 2020cited by 1,003position: middledoi
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Cancer Cell 2020cited by 376position: middledoi
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
Cell Reports Medicine 2020cited by 78position: middledoi
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Cancer Cell 2020cited by 53position: middledoi
A Landscape of Pharmacogenomic Interactions in Cancer
Cell 2016cited by 2,239position: middledoi
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Clinical Cancer Research 2016cited by 292position: middledoi
Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes.
Journal of Clinical Oncology 2015cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2015–2016)Brendan D. Curti · Providence Portland Medical Center2 papers (2015–2016)Charles G. Drake · Johnson & Johnson (United States)2 papers (2015–2016)Elizabeth R. Plimack · The University of Texas Southwestern Medical Center2 papers (2015–2016)— · 2 papers (2015–2016)José Luis Perez‐Gracia · Navarre Institute of Health Research2 papers (2015–2016)Bernard Escudier · Institut Gustave Roussy2 papers (2015–2016)Toni K. Choueiri · Harvard University2 papers (2015–2016)Lawrence Fong · Fred Hutch Cancer Center2 papers (2015–2016)— · 2 papers (2015–2016)Walter M. Stadler · Cancer Research UK2 papers (2015–2016)— · 2 papers (2015–2016)Michael R. Harrison · Duke University2 papers (2015–2016)Harriet M. Kluger · Yale Cancer Center2 papers (2015–2016)Mayer Fishman · University of Alabama at Birmingham2 papers (2015–2016)David F. McDermott · Dana-Farber/Harvard Cancer Center2 papers (2015–2016)Mario Sznol · Yale Cancer Center2 papers (2015–2016)Leonard J. Appleman · University of Pittsburgh1 papers (2015–2015)— · 1 papers (2020–2020)Rachel Karchin · University of Baltimore1 papers (2020–2020)